Skip to main content
Joseph Avruch, MD, Endocrinology, Boston, MA

JosephAvruchMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Professor of Medicine, Massachusetts General Hospital

Join to view full profile

Dr. Avruch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Avruch's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1969 - 1970
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Family Medicine, 1968 - 1969
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1965 - 1966
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1965
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1972 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1977
  • Investigator Alumnus Howard Hughes Medical Institute, 1974

Publications & Presentations

PubMed

Press Mentions

  • Gene Tweak Can Extend Life 500% (But You Have to Be a Worm)
    Gene Tweak Can Extend Life 500% (But You Have to Be a Worm)January 15th, 2020
  • Joseph Avruch, MD Speaking at Philip E. Cryer, MD Lecture
    Joseph Avruch, MD Speaking at Philip E. Cryer, MD LectureSeptember 6th, 2016
  • Clinical Trial Results Support Strategy for Reversing Type 1 Diabetes
    Clinical Trial Results Support Strategy for Reversing Type 1 DiabetesAugust 8th, 2012
  • Join now to see all

Grant Support

  • Decoding The MST1 And MST2 Kinases In Cellular Physiology And Tumor SuppressionNational Cancer Institute2010–2012
  • Phosphopeptide Metabolism In AdipocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2012
  • Training Program In EndocrinologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • The Boston Area Diabetes Endocrinology Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Broad InstituteNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Molecular Basis Of Cell Growth Control By The TOR KinaseNational Cancer Institute1997–2011
  • Core ENational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Core DNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Core CNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Core BNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Boston Area Diabetes Endocrinology Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2009
  • Training Program In Endocrinology And DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–2009
  • Molecular Mechanisms Of Burn Induced Insulin ResistanceNational Institute Of General Medical Sciences2004–2008
  • Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
  • Flow Cytometry CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Admin CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Phosphopeptide Metabolism In AdipocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1998
  • Conference On 2nd Messengers And Protein PhosphorylationNational Institute Of General Medical Sciences1994
  • Molecular Mediators Of Diabetic Renal HypertrophyNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1992
  • Physiologic Target Of The Insulin Receptor KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1991
  • Training Program In Endocrinology And DiabetesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
  • Phosphopeptide Metabolism In AdipocytesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Dr. Joseph Avruch, Dr. Joseph Avruch, MD, Dr. J Avruch